60 Degrees Pharmaceuticals, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.21-$12.45 |
Market Cap | $6M |
Shares Short | 79,479 |
Financials
See moreRevenue (12 Mos) | $984,494 |
Revenue Growth (YoY) | 144.9% |
Gross Profit (12 Mos) | $179,109 |
Diluted EPS | $0.08 |
News
See moreYahoo Finance • last month
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference
Yahoo Finance • 2 months ago
60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Yahoo Finance • 2 months ago
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
Yahoo Finance • 3 months ago
60 Degrees Pharmaceuticals announces pricing of up to $10 million public offering
About
CEO | Dr. Geoffrey Stuart Dow Ph.D. |
CFO | Mr. Tyrone Miller |
Address | 1025 Connecticut Avenue NW, Washington, DC, United States, 20036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3 |
